Ever thought of the difference between an ACL tear and an MCL tear Learn what makes the two different despite being located ...

MCL is a rare, often aggressive type of non-Hodgkin lymphoma, with more than 21,000 patients diagnosed across key global markets, including the US, UK, France, Germany, Spain, Italy, Japan, and China.

WILMINGTON, Del. - The U.S. Food and Drug Administration (FDA) has granted approval to AstraZeneca (NASDAQ:AZN)'s CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab for the ...

WILMINGTON, Del. - The U.S. Food and Drug Administration (FDA) has granted approval to AstraZeneca (NASDAQ:AZN)’s CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab for the ...